Didanosine - 65862-093-60 - (Didanosine)

Alphabetical Index


Drug Information of Didanosine

Product NDC: 65862-093
Proprietary Name: Didanosine
Non Proprietary Name: Didanosine
Active Ingredient(s): 150    mg/1 & nbsp;   Didanosine
Administration Route(s): ORAL
Dosage Form(s): TABLET, FOR SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of Didanosine

Product NDC: 65862-093
Labeler Name: Aurobindo Pharma Limited
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077275
Marketing Category: ANDA
Start Marketing Date: 20120814

Package Information of Didanosine

Package NDC: 65862-093-60
Package Description: 60 TABLET, FOR SUSPENSION in 1 BOTTLE (65862-093-60)

NDC Information of Didanosine

NDC Code 65862-093-60
Proprietary Name Didanosine
Package Description 60 TABLET, FOR SUSPENSION in 1 BOTTLE (65862-093-60)
Product NDC 65862-093
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Didanosine
Dosage Form Name TABLET, FOR SUSPENSION
Route Name ORAL
Start Marketing Date 20120814
Marketing Category Name ANDA
Labeler Name Aurobindo Pharma Limited
Substance Name DIDANOSINE
Strength Number 150
Strength Unit mg/1
Pharmaceutical Classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of Didanosine


General Information